Preclinical Evidence for Antidepressant-like Effects of Histamine H3 Receptor Modulation: A Systematic Review and Meta-Analysis. [PDF]
Pullano I +5 more
europepmc +1 more source
Histamine H3 Receptor Antagonists Influence the Directional Growth of Type II Spiral Ganglion Neurites Within the Developing Cochlea of C57BL/6 Mice. [PDF]
Kong L, Olze H, Szczepek AJ.
europepmc +1 more source
Excessive daytime sleepiness is a symptom found in patients with narcolepsy or sleep apnoea-hypopnoea syndrome (SAHOS). The first-line drug treatments for excessive daytime sleepiness, pitolisant and solriamfetol, may have different safety profiles.
Toth, Rémi
core
Optimizing patient outcomes and empowering the patient-clinician partnership. [PDF]
Thorpy M.
europepmc +1 more source
Personalized endpoints in Prader-Willi syndrome: a case study with goal attainment scaling. [PDF]
Revana A +6 more
europepmc +1 more source
Rational Design, Synthesis and Pharmacological Evaluation of Chalcones as Dual-Acting Compounds-Histamine H<sub>3</sub> Receptor Ligands and MAO-B Inhibitors. [PDF]
Łażewska D +15 more
europepmc +1 more source
Management of Central Disorders of Hypersomnolence in Pregnancy and Lactation. [PDF]
Abideen ZU +5 more
europepmc +1 more source
A Comprehensive Review of Current and Emerging Treatments for Narcolepsy Type 1. [PDF]
Xu Q +5 more
europepmc +1 more source
Development and validation of a method for quantitative determination of the genotoxic impurity diethyl sulfate in pitolisant hydrochloride <i>via</i> high-performance liquid chromatography. [PDF]
Bhagwat S +5 more
europepmc +1 more source
Antiseizure Medications that Did Not Reach the Epilepsy Market: An Assessment of Factors Contributing to Their Failed Clinical Development Over the Last Three Decades. [PDF]
Bialer M, Perucca E.
europepmc +1 more source

